Eagle Health Investments LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001842545
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 26 positions · Total reported value $570.22M · Top-10 concentration 67.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 54.8% · 4 new · 4 cut · 9 exited
Active Share (vs S&P 500): 99.7% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2024 13F filing, Eagle Health Investments LP disclosed 26 equity positions with a combined reported value of $570.22M. The filing implies a focused portfolio: its ten largest positions account for 67.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were UTHR ($53.36M), NTRA ($51.34M), ICLR ($46.89M). By sector, the heaviest allocations are Health Care 96.0%, Other 4.0%. Versus the prior quarter, allocation shifted toward Health Care (+7.5pp) and away from Industrials (-7.7pp).
Versus the prior quarter, Eagle Health Investments LP opened 4 new positions, trimmed 4 and fully exited 9, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 71% of names.
The largest new positions opened in Q2 2024 were UNH ($44.25M), INSM ($34.42M), BMRN ($19.08M).
Of the 9 positions fully exited versus the prior quarter, the largest were DHR ($28.39M), SRPT ($13.37M), FUSN ($12.36M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- UNH UNITEDHEALTH GROUP INC · $44.25M
- INSM INSMED INC · $34.42M
- BMRN BIOMARIN PHARMACEUTICAL INC · $19.08M
- GRAL GRAIL INC · $816.52K
Insider Transactions (Form 4)
Latest Eagle Health Investments LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Eagle Health Investments LP, based in Greenwich, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 27 positions worth $603.31M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: GREENWICH, CT, United States
- SEC registration: 801-121917 (status: Approved), registered 2021-07-29
- Regulatory AUM (Form ADV): $605.26M as of 2026-03-28
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 27 positions · $603.31M reported value (Q2 2026)
- Top 10 holdings = 66.1% of reported value
- Largest position: ARGX (ARGENX SE FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS) at 11.8%
- Average position size: $22.34M
Sector Tilt
- Health Care 96.0%
- Information Technology 2.5%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 5 new, 9 added, 4 reduced, 5 exited
- 9 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
167.50K | $53.36M | 9.36% | Reduce | |
| 2 |
|
474.11K | $51.34M | 9.00% | Reduce | |
| 3 |
|
149.59K | $46.89M | 8.22% | Hold | |
| 4 |
|
86.90K | $44.25M | 7.76% | New | |
| 5 |
|
88.89K | $38.23M | 6.70% | Add | |
| 6 |
|
513.70K | $34.42M | 6.04% | New | |
| 7 |
|
318.75K | $33.27M | 5.83% | Hold | |
| 8 |
|
275.72K | $31.26M | 5.48% | Reduce | |
| 9 |
|
121.89K | $25.77M | 4.52% | Hold | |
| 10 |
|
544.20K | $22.99M | 4.03% | Add | |
| 11 |
|
524.50K | $21.56M | 3.78% | Add | |
| 12 |
|
132.86K | $20.01M | 3.51% | Reduce | |
| 13 |
|
231.80K | $19.08M | 3.35% | New | |
| 14 |
|
76.26K | $18.53M | 3.25% | Add | |
| 15 |
|
136.60K | $18.28M | 3.21% | Add | |
| 16 |
|
626.91K | $18.11M | 3.17% | Reduce | |
| 17 |
|
257.09K | $15.71M | 2.75% | Reduce | |
| 18 |
|
330.83K | $14.27M | 2.50% | Hold | |
| 19 |
|
28.29K | $12.58M | 2.21% | Reduce | |
| 20 |
|
197.00K | $10.64M | 1.87% | Hold | |
| 21 |
|
462.91K | $9.72M | 1.70% | Hold | |
| 22 |
|
43.20K | $3.47M | 0.61% | Hold | |
| 23 |
|
45.00K | $2.39M | 0.42% | Hold | |
| 24 |
|
700.00K | $1.71M | 0.30% | Hold | |
| 25 |
|
46.30K | $1.57M | 0.28% | Hold | |
| 26 |
|
53.12K | $816.52K | 0.14% | New | |
FAQ
What did Eagle Health Investments LP buy in 2024-Q2?
In its 2024-Q2 13F filing, Eagle Health Investments LP reported 26 equity positions worth $570.22M in aggregate; its largest disclosed positions were UTHR ($53.36M), NTRA ($51.34M), ICLR ($46.89M).
How large is Eagle Health Investments LP's portfolio?
Eagle Health Investments LP reported $570.22M of long equity holdings across 26 positions as of 2024-Q2. Top-10 holdings account for 67.0% of reported value.
What is Eagle Health Investments LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.